Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No.119, South 4th Ring West Road, Fengtai District, Beijing, 100070, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
BMC Neurol. 2022 Mar 8;22(1):79. doi: 10.1186/s12883-022-02588-3.
Triglyceride-glucose (TyG) index has been considered a surrogate marker of insulin resistance. We investigated the association between TyG index and stroke recurrence and compared the effectiveness of TyG index with homeostasis model assessment of insulin resistance (HOMA-IR) in predicting stroke recurrence and death in nondiabetic acute ischemic stroke patients.
Nondiabetic acute ischemic stroke patients from the ACROSS-China (Abnormal Glucose Regulation in Patients with Acute Stroke across China) registry were included. TyG index was performed and classified into four groups by quartiles. The outcomes were stroke recurrence and death within 1 year. The association between TyG index and the risk of stroke recurrence and death were analyzed by Cox regression models. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the prediction of TyG index and HOMA-IR for stroke recurrence and death. Delong test was used for comparing the differences between area under the curve (AUC) of TyG index and HOMA-IR.
Among the 1226 patients included, the median (interquartile range) of TyG index was 5.8 (5.5-6.2). Both the third and fourth quartiles of TyG index were associated with an increased risk of stroke recurrence (adjusted hazard ratio 2.04, 95% confidence interval 1.26-3.31; adjusted hazard ratio 1.86, 95% confidence interval 1.13-3.06). Patients with fourth quartiles of TyG index were associated with a higher mortality risk (adjusted hazard ratio, 2.91; 95% confidence interval, 1.62-2.53). Regarding stroke recurrence within 1 year, the AUC (95% confidence interval) of the ROC curve for the TyG index was similar to that of the HOMA-IR[0.56 (0.52-0.61) vs 0.57 (0.52-0.61); P = 0.93]. Regarding death within 1 year, the AUCs (95% confidence interval) of the ROC curve for the TyG index and HOMA-IR were 0.55 (0.50-0.61) and 0.59 (0.53-0.64), respectively (P = 0.32).
Elevated TyG index was associated with an increased risk of stroke recurrence and death. However, neither of TyG nor HOMA-IR can be a qualified predictor of stroke recurrence and death in nondiabetic acute ischemic stroke patients.
甘油三酯-葡萄糖(TyG)指数已被认为是胰岛素抵抗的替代标志物。我们研究了 TyG 指数与中风复发之间的关系,并比较了 TyG 指数与稳态模型评估的胰岛素抵抗(HOMA-IR)在预测非糖尿病急性缺血性中风患者中风复发和死亡方面的有效性。
纳入来自中国急性卒中血糖异常登记研究(ACROSS-China)的非糖尿病急性缺血性卒中患者。进行 TyG 指数检测,并按四分位数将其分为四组。结局为 1 年内中风复发和死亡。采用 Cox 回归模型分析 TyG 指数与中风复发和死亡风险之间的关系。绘制受试者工作特征(ROC)曲线分析 TyG 指数和 HOMA-IR 对中风复发和死亡的预测价值。采用 Delong 检验比较 TyG 指数和 HOMA-IR 的曲线下面积(AUC)之间的差异。
在纳入的 1226 例患者中,TyG 指数的中位数(四分位间距)为 5.8(5.5-6.2)。TyG 指数的第三和第四四分位数与中风复发风险增加相关(校正后危险比 2.04,95%置信区间 1.26-3.31;校正后危险比 1.86,95%置信区间 1.13-3.06)。TyG 指数第四四分位数的患者死亡率较高(校正后危险比,2.91;95%置信区间,1.62-2.53)。关于 1 年内中风复发,TyG 指数的 ROC 曲线下面积(95%置信区间)与 HOMA-IR 相似[0.56(0.52-0.61)与 0.57(0.52-0.61);P=0.93]。关于 1 年内死亡,TyG 指数和 HOMA-IR 的 ROC 曲线下面积(95%置信区间)分别为 0.55(0.50-0.61)和 0.59(0.53-0.64)(P=0.32)。
升高的 TyG 指数与中风复发和死亡风险增加相关。然而,TyG 指数和 HOMA-IR 均不能作为非糖尿病急性缺血性中风患者中风复发和死亡的合格预测因子。